Trillium Therapeutics (TRIL) Announces 8.5M Share Proposed Public Offering of Common Shares

Go back to Trillium Therapeutics (TRIL) Announces 8.5M Share Proposed Public Offering of Common Shares

Trillium Therapeutics (TRIL) Prices 10M Share Common Offering at $13/Sh

September 11, 2020 5:51 AM EDT

Trillium Therapeutics Inc. (NASDAQ: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has priced its previously announced underwritten public offering of 10,000,000 common shares (the Common Shares) of the... More